Vonvendi

Indicated For

von Willebrand disease

About This Medication

# Takeda Patient Support Patient Guide: How to Get VONVendi at Low or No Cost VONVENDI (von Willebrand factor (recombinant)) is a specialized treatment for von Willebrand disease (VWD), and **Takeda Patient Support** offers co-pay assistance, free trial doses, and other resources to help eligible patients access it affordably.[1][4][5] This guide explains eligibility, application steps, and support options in simple terms to empower you in managing your treatment. ## About VONVENDI and Von Willebrand Disease Von Willebrand disease (VWD) is the most common inherited bleeding disorder, affecting how your blood clots due to missing or faulty von Willebrand factor (VWF), a protein essential for clotting.[7] VONVENDI is a **recombinant VWF**—made in a lab to mimic your body's natural VWF—used to prevent or treat bleeding episodes.[1][7] Approved uses include: - On-demand treatment for bleeding in adults and children with VWD. - Perioperative (surgery-related) bleeding management in adults and children. - Routine prophylaxis (preventive therapy) in adults with severe Type 3 VWD and now expanded to broader pediatric use.[7][10] It's infused intravenously, with a long half-life (about 22 hours in adults, 14 hours in children), often requiring just one dose for most non-surgical bleeds.[7] Always follow your doctor's dosing instructions, as it may be used alone or with recombinant factor VIII (rFVIII).[1] **Important Safety Note**: Do not use if you've had life-threatening allergic reactions to VONVENDI or its components (like polysorbate 80 or hamster/mouse proteins). Discuss risks with your doctor.[10] ## Who Qualifies for Takeda Patient Support? Takeda Patient Support is the main program for VONVENDI, providing personalized help including co-pay cards, insurance navigation, and free trial offers.[1][4] It's not a traditional income-based free drug program with strict Federal Poverty Level (FPL) limits; eligibility focuses on insurance status and prescription needs.[1][5][9] Key programs: - **Co-Pay Assistance**: For **commercially insured** patients. May cover 100% of out-of-pocket costs (co-pays, deductibles, coinsurance) up to a maximum. As low as **$5 per dose** for eligible patients.[1][9] - **Quick Start Program**: Free 30-day supply (3 doses for on-demand, 8 for prophylaxis) + up to two refills while awaiting insurance approval. For **new patients** with commercial insurance and FDA-approved use.[5] - **Help At Hand**: Free medicine for uninsured or underinsured patients based on financial need (VONVENDI eligibility confirmed via program site).[6][9] **Exclusions**: Medicare, Medicaid, TRICARE, or government insurance often ineligible for co-pay/Quick Start.[1][5] Uninsured may qualify via Help At Hand.[6] ## Income Eligibility Breakdown Unlike free drug programs tied to FPL (e.g., 400-500% FPL), Takeda programs prioritize insurance type over income, with Help At Hand assessing financial need case-by-case.[6][9] No specific income thresholds listed for VONVENDI co-pay or Quick Start—they require commercial insurance verification.[1][5] | Program | Insurance Required | Income Consideration | Max Benefit | Notes | |---------|---------------------|----------------------|-------------|--------| | **Co-Pay Assistance** | Commercial only | None specified | 100% OOP up to cap; $5/dose min | Enrollment + benefits check needed[1][9] | | **Quick Start** | Commercial only (no Medicare etc.) | None | 30 days + 2 refills free | New patients, on-label use[5] | | **Help At Hand** | None/uninsured/underinsured | Financial need-based | Free supply | VONVENDI confirmed eligible; apply separately[6][9] | Contact support for personalized eligibility—factors like household size aren't detailed publicly.[1] ## Insurance Requirements - **Commercial/Private Insurance**: Ideal for co-pay card and Quick Start. Program verifies benefits.[1][5] - **Medicare/Medicaid**: Typically ineligible for co-pay/Quick Start; explore Help At Hand or state programs.[5][6] - **Uninsured**: Help At Hand may provide free VONVENDI based on need.[6] Support specialists perform **benefits investigations** to confirm coverage and out-of-pocket costs.[1][4] ## Step-by-Step Application Process 1. **Talk to Your Doctor**: Confirm VONVENDI prescription for FDA-approved VWD use. Ask about Quick Start if new to therapy.[1][5] 2. **Enroll Online or Call**: Visit vonvendi.com/support or takedapatientsupport.com. Call **1-888-229-8379** (Mon-Fri 8am-8pm ET) for help.[1][2] 3. **Complete Enrollment Form**: Doctor and patient sign (pages 3-4). Include prescription details. For Quick Start, ePrescribe to **TheraCom Specialty Pharmacy**.[5] 4. **Submit**: Fax to **1-866-467-7740**. Or use online portal.[1][5] 5. **Verification**: Support reviews eligibility, runs benefits check. You'll hear if approved.[1] 6. **Receive Help**: Co-pay card digitally/mailed; Quick Start ships from pharmacy.[5] Nursing support and rep locator available for questions.[1][10] ## Timeline and Delivery - **Processing**: Varies; Quick Start ships upon verification (aim for quick access).[5] - **Delivery**: Via specialty pharmacy like TheraCom. Home shipment or site-of-care.[1][5] - **Support Hours**: Phone M-F 8am-8pm ET; online 24/7.[1] Expect 1-2 weeks for full setup, faster for urgent Quick Start.[1] ## Alternatives if Denied or Ineligible - **Appeal Insurance Denial**: Support helps with prior authorizations.[1] - **Other Takeda Programs**: Help At Hand if uninsured.[6] - **General Resources**: PAN Foundation, HealthWell Foundation for bleeding disorders (check eligibility).[9] - **Patient Access Networks**: NeedyMeds.org for VWD-specific aid. - **Doctor Discussion**: Switch to plasma-derived VWF or biosimilars if available (none listed for VONVENDI).[7] - **State Assistance**: Medicaid extra help for government insured. ## Disclaimer This guide summarizes public info as of available data; programs change.[1][5] Not medical/financial advice—consult your doctor and call **1-888-229-8379** for current details. Eligibility not guaranteed; void where prohibited. See full terms at takedapatientsupport.com.[1][4]

Program information last verified: March 30, 2026